These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 306344)

  • 21. Functional markers: a new perspective on malignant lymphomas.
    Jaffe ES; Braylan RC; Nanba K; Frank MM; Berard CW
    Cancer Treat Rep; 1977 Sep; 61(6):953-62. PubMed ID: 302739
    [No Abstract]   [Full Text] [Related]  

  • 22. Human lymphocyte populations in blood after tetanus vaccination.
    Enk C; Jønsson V; Christensen BE
    Scand J Haematol; 1980 Feb; 24(2):181-6. PubMed ID: 6990469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
    Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration in cell-mediated immunity in patients with chronic active hepatitis. I. Lymphocyte subpopulations.
    Ponzetto A; Arrigoni A
    G Batteriol Virol Immunol; 1979; 72(1-6):28-32. PubMed ID: 317950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological diagnosis of leukaemia and lymphoma: a World Health Organization/International Union of Immunological Societies technical report.
    Br J Haematol; 1978 Jan; 38(1):85-98. PubMed ID: 76475
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic markers of non-Hodgkin's lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Recent Results Cancer Res; 1978; 64():138-45. PubMed ID: 366692
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic significance of lymphocyte surface markers in adult non-Hodgkin's malignant lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Lancet; 1976 Dec; 2(7999):1330-3. PubMed ID: 63805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-and B-cell lymphomas look alike.
    Palutke M; Schnitzer B; Mirchandani I; Tabaczka P; Perrota A; Eisenberg L; Nathan LE; Gorrin G
    Am J Clin Pathol; 1980 Sep; 74(3):360-2. PubMed ID: 6968156
    [No Abstract]   [Full Text] [Related]  

  • 30. ATYPICAL SURFACE MAKER CHARACTERISTICS IN A T-cell lymphoma.
    Janossy G; McVerry BA; Goldstone AH; Souhami RL; Cawley JC; Thompson DS
    Scand J Haematol; 1977 Oct; 19(4):411-5. PubMed ID: 303372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the high- and low-affinity rosette-forming T-lymphocytes in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Kadhim S; Rees RC; Potter CW; Walker R; Hancock BW
    Eur J Cancer (1965); 1981 May; 17(5):569-75. PubMed ID: 6975211
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia.
    Baccarani M; Gobbi M; Tura S
    N Engl J Med; 1980 Jan; 302(2):123. PubMed ID: 6965316
    [No Abstract]   [Full Text] [Related]  

  • 33. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T and B lymphocytes during pregnancy.
    Sabolović N; de Romemont D
    Biomedicine; 1978 Oct; 29(6):212-7. PubMed ID: 310693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [T- and B-cellular marker study in chronic lympholeukemia].
    Tsveĭbakh AS
    Probl Gematol Pereliv Krovi; 1978; 23(11):20-4. PubMed ID: 309605
    [No Abstract]   [Full Text] [Related]  

  • 36. T and B lymphocytes in the ontogenetic development of man.
    Nowak J; Szymczyński G
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):159-63. PubMed ID: 312633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of T-lymphocytes and B-lymphocytes].
    Nakagawa T; Yata J
    Nihon Rinsho; 1976; 34 suppl():2653-71. PubMed ID: 792528
    [No Abstract]   [Full Text] [Related]  

  • 38. Spontaneous AKR lymphoma with T and B-cell characteristics.
    Greenberg RS; Zatz MM
    Nature; 1975 Sep; 257(5524):314-6. PubMed ID: 1080549
    [No Abstract]   [Full Text] [Related]  

  • 39. T- and B-lymphocyte subpopulations following radiotherapy for invasive squamous cell carcinoma of the uterine cervix.
    Rand RJ; Jenkins DM; Bulmer R
    Clin Exp Immunol; 1978 Jul; 33(1):159-65. PubMed ID: 309370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocompetence and malignant lymphoma: immunologic status before therapy.
    Anderson TC; Jones SE; Soehnlen BJ; Moon TE; Griffith K; Stanley P
    Cancer; 1981 Dec; 48(12):2702-9. PubMed ID: 6458352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.